HEMOGENYX PHARMPLC (Germany) Analysis
| 5HU Stock | EUR 3.98 0.08 2.05% |
HEMOGENYX PHARMPLC LS 01 is overvalued with Real Value of 3.18 and Hype Value of 3.98. The main objective of HEMOGENYX PHARMPLC stock analysis is to determine its intrinsic value, which is an estimate of what HEMOGENYX PHARMPLC LS 01 is worth, separate from its market price. There are two main types of HEMOGENYX PHARMPLC's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect HEMOGENYX PHARMPLC's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of HEMOGENYX PHARMPLC's stock to identify patterns and trends that may indicate its future price movements.
The HEMOGENYX PHARMPLC stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and HEMOGENYX PHARMPLC's ongoing operational relationships across important fundamental and technical indicators.
HEMOGENYX |
HEMOGENYX Stock Analysis Notes
About 15.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 0.01. HEMOGENYX PHARMPLC had not issued any dividends in recent years. The entity had 400:1 split on the 6th of December 2024. Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was incorporated in 2013 and is headquartered in London, the United Kingdom. HEMOGENYX PHARM is traded on Frankfurt Stock Exchange in Germany. For more info on HEMOGENYX PHARMPLC LS 01 please contact the company at 44 79 0917 7311 or go to http://www.hemogenyx.com.HEMOGENYX PHARMPLC Investment Alerts
| HEMOGENYX PHARMPLC is not yet fully synchronised with the market data | |
| HEMOGENYX PHARMPLC generated a negative expected return over the last 90 days | |
| HEMOGENYX PHARMPLC has high historical volatility and very poor performance | |
| Net Loss for the year was (2.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| HEMOGENYX PHARMPLC LS 01 has accumulated about 1.81 M in cash with (1.8 M) of positive cash flow from operations. | |
| Roughly 15.0% of the company shares are owned by insiders or employees |
HEMOGENYX Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.89 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HEMOGENYX PHARMPLC's market, we take the total number of its shares issued and multiply it by HEMOGENYX PHARMPLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.HEMOGENYX PHARMPLC Outstanding Bonds
HEMOGENYX PHARMPLC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. HEMOGENYX PHARMPLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most HEMOGENYX bonds can be classified according to their maturity, which is the date when HEMOGENYX PHARMPLC LS 01 has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
HEMOGENYX PHARMPLC Predictive Daily Indicators
HEMOGENYX PHARMPLC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of HEMOGENYX PHARMPLC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About HEMOGENYX Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how HEMOGENYX PHARMPLC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling HEMOGENYX shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as HEMOGENYX PHARMPLC. By using and applying HEMOGENYX Stock analysis, traders can create a robust methodology for identifying HEMOGENYX entry and exit points for their positions.
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was incorporated in 2013 and is headquartered in London, the United Kingdom. HEMOGENYX PHARM is traded on Frankfurt Stock Exchange in Germany.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding HEMOGENYX PHARMPLC to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Complementary Tools for HEMOGENYX Stock analysis
When running HEMOGENYX PHARMPLC's price analysis, check to measure HEMOGENYX PHARMPLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HEMOGENYX PHARMPLC is operating at the current time. Most of HEMOGENYX PHARMPLC's value examination focuses on studying past and present price action to predict the probability of HEMOGENYX PHARMPLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HEMOGENYX PHARMPLC's price. Additionally, you may evaluate how the addition of HEMOGENYX PHARMPLC to your portfolios can decrease your overall portfolio volatility.
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |